enkephalinamide-met, ala(2)- has been researched along with 3,4-dihydroxyphenylacetic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Algeri, S; De Simoni, MG; Guardabasso, V; Misterek, K | 1 |
Barson, JR; Hoebel, BG; Leibowitz, SF; Rada, P | 1 |
2 other study(ies) available for enkephalinamide-met, ala(2)- and 3,4-dihydroxyphenylacetic acid
Article | Year |
---|---|
Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catalepsy; Corpus Striatum; Dopamine; Drug Tolerance; Enkephalin, Methionine; Humans; Limbic System; Male; Morphine; Rats; Substantia Nigra | 1982 |
Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Analgesics, Opioid; Animals; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Methionine; Homovanillic Acid; Male; Microdialysis; Microinjections; Morphine; Naloxone; Narcotic Antagonists; Neural Pathways; Nucleus Accumbens; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley | 2010 |